Ursodeoxycholic Acid in Patients With Treatment-Resistant Schizophrenia Suffering From Coronavirus Disease 2019: A Hypothesis Letter

Ursodeoxycholic Acid in Patients With Treatment-Resistant Schizophrenia Suffering From Coronavirus Disease 2019: A Hypothesis Letter

Bibliographic Details
Main Author:	Mohsen Khosravi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-04-01
Series:	Frontiers in Psychiatry
Subjects:	coronavirus disease 2019 patient schizophrenia treatment ursodeoxycholic acid
Online Access:	https://www.frontiersin.org/articles/10.3389/fpsyt.2021.657316/full

Similar Items

Ursodeoxycholic acid augmentation in treatment-refractory schizophrenia: a case report
by: Mohsen Khosravi
Published: (2020-09-01)

Lewy body dementia: Ursodeoxycholic acid as a putative treatment for gastrointestinal dysfunction
by: Mohsen Khosravi
Published: (2021-06-01)

Protective effect of ursodeoxycholic acid on COVID-19 in patients with chronic liver disease
by: Yanyan Li, et al.
Published: (2023-05-01)

Merit of an Ursodeoxycholic Acid Clinical Trial in COVID-19 Patients
by: Subbaya Subramanian, et al.
Published: (2020-06-01)

Clinical efficacy of ursodeoxycholic acid in the comprehensive treatment of patients with obesity and gastroesophageal reflux disease
by: Ye.S. Sirchak
Published: (2018-11-01)

Experience of using ursodeoxycholic acid in the therapy of biliary sludge in children
by: O.Yu. Belousova, et al.
Published: (2018-04-01)

Reductive effect of ursodeoxycholic acid on bilirubin levels in neonates on phototherapy
by: Ughasoro MD, et al.
Published: (2019-07-01)

Optimizing the Treatment of Atopic Dermatitis in Infants Using Ursodeoxycholic Acid
by: O.H. Shadrin, et al.
Published: (2016-08-01)

Ursodeoxycholic acid: A therapeutic niche in an internist’s practice
by: O M Drapkina, et al.
Published: (2015-04-01)

Protective effects of ursodeoxycholic acid on ceftriaxone-induced hepatic injury in rats
by: Khaled A. Alhumaidha, et al.
Published: (2014-06-01)

Experience of Using Ursodeoxycholic Acid in Children with Organic Diseases of the Liver
by: Ye.N. Babadzhanian
Published: (2015-03-01)

Influence of ursodeoxycholic acid on insulin resistance in patients with metabolic syndrome
by: V.I. Pankiv
Published: (2018-04-01)

Results of the non-interventional observational program: Influence of Novel COroNavirus on the condition of patients with liver and gastrointestinal Tract diseases and the effect of Ursodeoxycholic acid drugs and Rebamipide on the course of COVID-19 infection (CONTUR)
by: I. N. Tikhonov, et al.
Published: (2022-01-01)

Coronavirus disease COVID-2019
by: B. K. Romanov
Published: (2020-03-01)

THE ROLE OF URSODEOXYCHOLIC ACID IN THE TREATMENT OF CHRONIC VIRAL HEPATITIS
by: R. G. MYAZIN
Published: (2017-05-01)

Pleiotropic effects of ursodeoxycholic acid
by: Yu.М. Stepanov, et al.
Published: (2021-06-01)

Ursodeoxycholic acid in neonatal sepsis-associated cholestasis
by: Rita Mey Rina, et al.
Published: (2014-08-01)

Use of ursodeoxycholic acid in patients with hypertransaminasemia
by: Claudio Puoti, et al.
Published: (2014-09-01)

Fibrates for the Treatment of Primary Biliary Cholangitis Unresponsive to Ursodeoxycholic Acid: An Exploratory Study
by: Guilherme Grossi Lopes Cançado, et al.
Published: (2022-01-01)

Preventive effect of ursodeoxycholic acid on parenteral nutrition-associated liver disease in infants
by: Simić Dušica, et al.
Published: (2014-01-01)

Role of Ursodeoxycholic Acid in Treating and Preventing Idiosyncratic Drug-Induced Liver Injury. A Systematic Review
by: Mercedes Robles-Díaz, et al.
Published: (2021-10-01)

Gastrointestinal symptoms in patients with coronavirus disease 2019 (COVID-19) – friend or foe?
by: Konrad Lewandowski, et al.
Published: (2021-11-01)

Glyceric Prodrug of Ursodeoxycholic Acid (UDCA): Novozym 435-Catalyzed Synthesis of UDCA-Monoglyceride
by: Federico Zappaterra, et al.
Published: (2021-10-01)

Ursodeoxycholic acid: paradigmatic transformation of the prevention of drug-induced liver lesions in clinical practice
by: Maksim Potjagenko, et al.
Published: (2017-03-01)

Biological synthesis of ursodeoxycholic acid
by: Peng Song, et al.
Published: (2023-02-01)

Looking Into the Crystal Ball: Predicting Non-response to Ursodeoxycholic Acid in Primary Biliary Cholangitis
by: Vincent Zimmer, et al.
Published: (2017-02-01)

May Ursodeoxycholic Acid Significantly Improve Liver Function Tests among Patients with Hepatitis C?
by: Alpaslan Tanoglu, et al.
Published: (2015-12-01)

Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemia
by: Adrian M. Di Bisceglie, et al.
Published: (2020-11-01)

Obstetric Cholestasis: Comparison of Maternal and Perinatal Outcome of Ursodeoxycholic Acid versus Placebo
by: Faiza Safdar, et al.
Published: (2020-03-01)

Role of ursodeoxycholic acid in prevention of hepatotoxicity caused by amoxicillin-clavulanic acid in rats
by: Gamal A. El-Sherbiny, et al.
Published: (2009-04-01)

Ursodeoxycholic acid and its unexpected application areas
by: A. R. Reyzis
Published: (2020-05-01)

Overview of Bile Acids Signaling and Perspective on the Signal of Ursodeoxycholic Acid, the Most Hydrophilic Bile Acid, in the Heart
by: Noorul Izzati Hanafi, et al.
Published: (2018-11-01)

Post-coronavirus disease 2019 children in Sarajevo-Lessons learnt?
by: Senka Mesihovic-Dinarevic, et al.
Published: (2021-07-01)

Protective Effect of Ursodeoxycholic Acid in Experimental Endometriosis Induced Rat Model
by: Ali Seven, et al.
Published: (2023-11-01)

Ursodeoxycholic Acid May Inhibit Environmental Aging-Associated Hyperpigmentation
by: Ik Jun Moon, et al.
Published: (2021-02-01)

Ursodeoxycholic acid production by Gibberella zeae mutants
by: Vyacheslav Kollerov, et al.
Published: (2022-08-01)

Evaluation of therapeutic efficiency of various drugs of ursodeoxycholic acid in the treatment of biliary sludge
by: Albina R. Isanbaeva, et al.
Published: (2021-12-01)

Ursodeoxycholic acid attenuates hepatotoxicity of multidrug treatment of mycobacterial infections: A prospective pilot study
by: Susanne M Lang, et al.
Published: (2019-01-01)

Ursodeoxycholic Acid Regulates Hepatic Energy Homeostasis and White Adipose Tissue Macrophages Polarization in Leptin-Deficiency Obese Mice
by: Yu-Sheng Chen, et al.
Published: (2019-03-01)

Use of Ursodeoxycholic Acid on Post-menopausal Obesity, Hepatic steatosis and Plasma Profile as an Alternative Treatment for Hormone Replacement Therapy
by: Angelo Christiano Franzoni, et al.
Published: (2015-12-01)